<DOC>
	<DOCNO>NCT01514227</DOCNO>
	<brief_summary>NIPPON trial prospective , randomize , trial compare 6 18 month Dual Antiplatelet Therapy ( DAPT ) follow Nobori stent deployment .</brief_summary>
	<brief_title>Nobori Dual Antiplatelet Therapy Appropriate Duration</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Subjects &gt; 20 year old Undergoing percutaneous intervention Nobori deployment No contraindication prolong DAPT Subjects absolutely necessitate continuous DAPT Planned surgery necessitating discontinuation antiplatelet therapy enrollment . Active pathological bleeding Status cardiogenic shock enrollment Pregnant woman Life expectancy &lt; 1.5 year Subjects unable give inform consent Episode stroke &lt; 6 month Subjects allergies hypersensitivity material coating , Biolimus A9 , antiplatelet drug . Subjects treat kind DES BMS index procedure Previous intervention DES &lt; 6 month . Study participation impractical per investigator judgment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>